The Edwards Lifesciences Dilemma Persists: Strong Growth Potential, High Price (NYSE:EW)

Core Viewpoint - High valuations do not necessarily prevent further market-beating gains but tend to increase volatility, with Edwards Lifesciences (EW) exemplifying this trend [1]. Group 1 - Edwards Lifesciences continues to demonstrate impressive growth relative to its size [1].